EZH2 and familial pancreatic carcinoma: AGAP2-AS1 worked synchronously with EZH2 (enhancer of zeste homolog-2) and epigenetically inhibited ANGPTL4 and ANKRD1 and fueled proliferation and metastasis of pancreatic cancer cells (52).